147 related articles for article (PubMed ID: 31247124)
1. National survey of prevalence and prognosis of thanatophoric dysplasia in Japan.
Sawai H; Oka K; Ushioda M; Nishimura G; Omori T; Numabe H; Kosugi S
Pediatr Int; 2019 Aug; 61(8):748-753. PubMed ID: 31247124
[TBL] [Abstract][Full Text] [Related]
2. Development of individuals with thanatophoric dysplasia surviving beyond infancy.
Ushioda M; Sawai H; Numabe H; Nishimura G; Shibahara H
Pediatr Int; 2022 Jan; 64(1):e15007. PubMed ID: 34597445
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of thanatophoric dysplasia and lethal osteogenesis imperfecta type II in Northern Ireland - a complete population study.
Donnelly DE; McConnell V; Paterson A; Morrison PJ
Ulster Med J; 2010 Sep; 79(3):114-8. PubMed ID: 22375084
[TBL] [Abstract][Full Text] [Related]
4. Nationwide epidemiological survey of holoprosencephaly in Japan.
Abe Y; Araki R; Sobajima H; Tamura M; Kunikata T; Ohtake A; Yamanouchi H
Pediatr Int; 2020 May; 62(5):593-599. PubMed ID: 31886593
[TBL] [Abstract][Full Text] [Related]
5. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US.
Waller DK; Correa A; Vo TM; Wang Y; Hobbs C; Langlois PH; Pearson K; Romitti PA; Shaw GM; Hecht JT
Am J Med Genet A; 2008 Sep; 146A(18):2385-9. PubMed ID: 18698630
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of the temporal bones in thanatophoric dysplasia.
Sano M; Sakagami M; Harada T; Matsunaga T; Tominaga Y; Nakayama M
Med J Osaka Univ; 1991 Mar; 40(1-4):51-7. PubMed ID: 1369657
[TBL] [Abstract][Full Text] [Related]
7. Camptomelic dysplasia: a case study.
Soell J
Neonatal Netw; 1999 Mar; 18(2):41-8. PubMed ID: 10362999
[TBL] [Abstract][Full Text] [Related]
8. Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months.
Soo-Kyeong J; Lee N; Bae MH; Han YM; Hee Park K; Byun SY
Fetal Pediatr Pathol; 2018 Oct; 37(5):363-371. PubMed ID: 30252581
[TBL] [Abstract][Full Text] [Related]
9. Congenital limb deficiency in Japan: a cross-sectional nationwide survey on its epidemiology.
Mano H; Fujiwara S; Takamura K; Kitoh H; Takayama S; Ogata T; Hashimoto S; Haga N
BMC Musculoskelet Disord; 2018 Jul; 19(1):262. PubMed ID: 30053842
[TBL] [Abstract][Full Text] [Related]
10. The birth prevalence rates for the skeletal dysplasias.
Orioli IM; Castilla EE; Barbosa-Neto JG
J Med Genet; 1986 Aug; 23(4):328-32. PubMed ID: 3746832
[TBL] [Abstract][Full Text] [Related]
11. Bone dysplasias in 1.6 million births in Argentina.
Duarte SP; Rocha ME; Bidondo MP; Liascovich R; Barbero P; Groisman B
Eur J Med Genet; 2019 Dec; 62(12):103603. PubMed ID: 30572171
[TBL] [Abstract][Full Text] [Related]
12. Analysis of skeletal dysplasias in the Utah population.
Stevenson DA; Carey JC; Byrne JL; Srisukhumbowornchai S; Feldkamp ML
Am J Med Genet A; 2012 May; 158A(5):1046-54. PubMed ID: 22461456
[TBL] [Abstract][Full Text] [Related]
13. Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant.
Connor JM; Connor RA; Sweet EM; Gibson AA; Patrick WJ; McNay MB; Redford DH
Am J Med Genet; 1985 Oct; 22(2):243-53. PubMed ID: 3901754
[TBL] [Abstract][Full Text] [Related]
14. Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia.
Wang DC; Shannon P; Toi A; Chitayat D; Mohan U; Barkova E; Keating S; Tomlinson G; Glanc P
Ultrasound Obstet Gynecol; 2014 Nov; 44(5):588-94. PubMed ID: 24585534
[TBL] [Abstract][Full Text] [Related]
15. Thanatophoric dysplasia: an autosomal dominant condition?
Martínez-Frías ML; Ramos-Arroyo MA; Salvador J
Am J Med Genet; 1988 Dec; 31(4):815-20. PubMed ID: 3239573
[TBL] [Abstract][Full Text] [Related]
16. Pediatric chronic intestinal pseudo-obstruction is a rare, serious, and intractable disease: a report of a nationwide survey in Japan.
Muto M; Matsufuji H; Tomomasa T; Nakajima A; Kawahara H; Ida S; Ushijima K; Kubota A; Mushiake S; Taguchi T
J Pediatr Surg; 2014 Dec; 49(12):1799-803. PubMed ID: 25487487
[TBL] [Abstract][Full Text] [Related]
17. Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation.
Jung M; Park SH
Exp Mol Pathol; 2017 Apr; 102(2):290-295. PubMed ID: 28249712
[TBL] [Abstract][Full Text] [Related]
18. A THANATOPHORIC DYSPLASIA TYPE I CASE WITH A FGFR3 P.R248C MUTATION AND SURVIVAL BEYOND THE NEONATAL PERIOD.
Sahin S; Ograg H; Aslan EA; Akcan AB; Turkmen MK; Moosa S; Elcioglu NH
Genet Couns; 2016; 27(4):513-517. PubMed ID: 30226972
[TBL] [Abstract][Full Text] [Related]
19. Thanatophoric dysplasia: role of 3-dimensional sonography.
Tsai PY; Chang CH; Yu CH; Cheng YC; Chang FM
J Clin Ultrasound; 2009 Jan; 37(1):31-4. PubMed ID: 18837426
[TBL] [Abstract][Full Text] [Related]
20. Current incidence of clinical kernicterus in preterm infants in Japan.
Morioka I; Nakamura H; Koda T; Yokota T; Okada H; Katayama Y; Kunikata T; Kondo M; Nakamura M; Hosono S; Yasuda S; Yokoyama N; Wada H; Itoh S; Funato M; Yamauchi Y; Lee YK; Yonetani M
Pediatr Int; 2015 Jun; 57(3):494-7. PubMed ID: 26113317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
